Common Stock, Shares, Issued of ALTEROLA BIOTECH INC. from 05 Jan 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
ALTEROLA BIOTECH INC. quarterly Common Stock, Shares, Issued in shares history and change rate from 05 Jan 2010 to 30 Sep 2024.
  • ALTEROLA BIOTECH INC. Common Stock, Shares, Issued for the quarter ending 30 Sep 2024 was 1,467,475,449, a 89% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

ALTEROLA BIOTECH INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 1,467,475,449 +689,443,497 +89% 30 Sep 2024 10-Q 29 Nov 2024 2025 Q2
Q2 2024 1,467,475,452 +660,427,504 +82% 30 Jun 2024 10-Q/A 25 Nov 2024 2025 Q1
Q1 2024 1,382,662,949 +575,615,001 +71% 31 Mar 2024 10-Q 29 Nov 2024 2025 Q2
Q4 2023 1,382,662,952 +575,615,004 +71% 31 Dec 2023 10-Q/A 21 Feb 2024 2024 Q3
Q3 2023 778,031,952 -29,015,996 -3.6% 30 Sep 2023 10-Q 29 Nov 2024 2025 Q2
Q2 2023 807,047,948 +4,414,615 +0.55% 30 Jun 2023 10-Q/A 25 Nov 2024 2025 Q1
Q1 2023 807,047,948 +4,134,615 +0.52% 31 Mar 2023 10-Q 29 Nov 2024 2025 Q2
Q4 2022 807,047,948 +20,747,948 +2.6% 31 Dec 2022 10-Q/A 21 Feb 2024 2024 Q3
Q3 2022 807,047,948 +45,267,948 +5.9% 30 Sep 2022 10-Q 21 Nov 2022 2023 Q2
Q2 2022 802,633,333 +48,353,333 +6.4% 30 Jun 2022 10-Q 18 Aug 2022 2023 Q1
Q1 2022 802,913,333 +48,633,333 +6.4% 31 Mar 2022 10-Q/A 21 Feb 2024 2024 Q3
Q4 2021 786,300,000 +653,120,000 +490% 31 Dec 2021 10-Q 01 Mar 2022 2022 Q3
Q3 2021 761,780,000 +631,800,000 +486% 30 Sep 2021 10-Q 21 Nov 2022 2023 Q2
Q2 2021 754,280,000 +637,300,000 +545% 30 Jun 2021 10-Q 19 Aug 2021 2022 Q1
Q1 2021 754,280,000 +637,300,000 +545% 31 Mar 2021 10-K/A 14 Sep 2022 2022 FY
Q4 2020 133,180,000 +16,200,000 +14% 31 Dec 2020 10-Q 28 May 2021 2021 Q1
Q3 2020 129,980,000 +13,000,000 +11% 30 Sep 2020 10-KT 09 Jun 2021 2021 FY
Q2 2020 116,980,000 +1,000,000 +0.86% 30 Jun 2020 10-Q 14 May 2021 2020 Q3
Q1 2020 116,980,000 +1,000,000 +0.86% 31 Mar 2020 10-Q 13 May 2021 2020 Q2
Q4 2019 116,980,000 +1,000,000 +0.86% 31 Dec 2019 10-Q 02 Apr 2021 2020 Q1
Q3 2019 116,980,000 +1,000,000 +0.86% 30 Sep 2019 10-KT 09 Jun 2021 2021 FY
Q2 2019 115,980,000 0 0% 30 Jun 2019 10-Q 09 Mar 2021 2019 Q3
Q1 2019 115,980,000 +1,000,000 +0.87% 31 Mar 2019 10-Q 24 Feb 2021 2019 Q2
Q4 2018 115,980,000 +1,000,000 +0.87% 31 Dec 2018 10-Q 29 Dec 2020 2019 Q1
Q3 2018 115,980,000 +1,000,000 +0.87% 30 Sep 2018 10-K 26 Mar 2021 2019 FY
Q2 2018 115,980,000 +1,000,000 +0.87% 30 Jun 2018 10-Q 07 Oct 2020 2018 Q3
Q1 2018 114,980,000 0 0% 31 Mar 2018 10-Q 24 Jan 2019 2018 Q2
Q4 2017 114,980,000 0 0% 31 Dec 2017 10-Q 11 Jan 2019 2018 Q1
Q3 2017 114,980,000 0 0% 30 Sep 2017 10-K 14 Dec 2020 2018 FY
Q2 2017 114,980,000 0 0% 30 Jun 2017 10-Q 10 Sep 2018 2017 Q3
Q1 2017 114,980,000 0 0% 31 Mar 2017 10-Q 06 Sep 2018 2017 Q2
Q4 2016 114,980,000 0 0% 31 Dec 2016 10-Q 30 Aug 2018 2017 Q1
Q3 2016 114,980,000 0 0% 30 Sep 2016 10-K 17 Dec 2018 2017 FY
Q2 2016 114,980,000 0 0% 30 Jun 2016 10-Q 06 Aug 2018 2016 Q3
Q1 2016 114,980,000 0 0% 31 Mar 2016 10-Q 16 May 2016 2015 Q2
Q4 2015 114,980,000 0 0% 31 Dec 2015 10-Q 05 Feb 2016 2016 Q1
Q3 2015 114,980,000 0 0% 30 Sep 2015 10-K 30 Aug 2018 2016 FY
Q2 2015 114,980,000 0 0% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q3
Q1 2015 114,980,000 0 0% 31 Mar 2015 10-Q 08 May 2015 2015 Q2
Q4 2014 114,980,000 0 0% 31 Dec 2014 10-Q 23 Feb 2015 2015 Q1
Q3 2014 114,980,000 +37,000,000 +47% 30 Sep 2014 10-K 30 Dec 2015 2015 FY
Q2 2014 114,980,000 +37,000,000 +47% 30 Jun 2014 10-Q 13 Aug 2014 2014 Q3
Q1 2014 114,980,000 +37,000,000 +47% 31 Mar 2014 10-Q 20 May 2014 2014 Q2
Q4 2013 114,980,000 +37,000,000 +47% 31 Dec 2013 10-Q 14 May 2014 2014 Q1
Q3 2013 77,980,000 0 0% 30 Sep 2013 10-Q 08 May 2015 2015 Q2
Q2 2013 77,980,000 0 0% 30 Jun 2013 10-Q 17 Mar 2014 2013 Q3
Q1 2013 77,980,000 0 0% 31 Mar 2013 10-Q 17 Mar 2014 2013 Q2
Q4 2012 77,980,000 0 0% 31 Dec 2012 10-Q 17 Mar 2014 2013 Q1
Q3 2012 77,980,000 0 0% 30 Sep 2012 10-K 13 May 2014 2013 FY
Q2 2012 77,980,000 0 0% 30 Jun 2012 10-Q 07 Mar 2014 2012 Q3
Q1 2012 77,980,000 31 Mar 2012 10-Q 07 Mar 2014 2012 Q2
Q4 2011 77,980,000 31 Dec 2011 10-Q 05 Mar 2014 2012 Q1
Q3 2011 77,980,000 -14,750,000 -16% 30 Sep 2011 10-K 11 Mar 2014 2012 FY
Q2 2011 77,980,000 30 Jun 2011 10-Q 06 Sep 2013 2011 Q3
Q3 2010 92,730,000 30 Sep 2010 10-K 27 Feb 2014 2011 FY
Q1 2010 55,000,000 03 May 2010 10-Q 20 May 2014 2014 Q2
Q4 2009 33,330,000 05 Jan 2010 10-Q 30 Aug 2018 2017 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.